Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Several studies have reported the incidence of interstitial pneumonia (IP) among patients with nonHodgkin lymphoma (NHL) that are undergoing combination chemotherapy plus rituximab; however, the effective prophylactic treatment for IP remains unclear. |